A business portfolio operated and disclosed on an ongoing basis under a four-reporting-segment structure centered on prescription pharmaceutical wholesaling and combining self-medication, pharmaceutical manufacturing and dispensing pharmacies. The company subsequently renamed the dispensing pharmacy and related business and established a new Other category that includes regenerative medicine-related operations.